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Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) establishes a latent infection in the host following an acute infection.
Reactivation from latency contributes to the development of KSHV-induced malignancies, which include Kaposi’s sarcoma
(KS), the most common cancer in untreated AIDS patients, primary effusion lymphoma and multicentric Castleman’s
disease. However, the physiological cues that trigger KSHV reactivation remain unclear. Here, we show that the reactive
oxygen species (ROS) hydrogen peroxide (H2O2) induces KSHV reactivation from latency through both autocrine and
paracrine signaling. Furthermore, KSHV spontaneous lytic replication, and KSHV reactivation from latency induced by
oxidative stress, hypoxia, and proinflammatory and proangiogenic cytokines are mediated by H2O2. Mechanistically, H2O2
induction of KSHV reactivation depends on the activation of mitogen-activated protein kinase ERK1/2, JNK, and p38
pathways. Significantly, H2O2 scavengers N-acetyl-L-cysteine (NAC), catalase and glutathione inhibit KSHV lytic replication in
culture. In a mouse model of KSHV-induced lymphoma, NAC effectively inhibits KSHV lytic replication and significantly
prolongs the lifespan of the mice. These results directly relate KSHV reactivation to oxidative stress and inflammation, which
are physiological hallmarks of KS patients. The discovery of this novel mechanism of KSHV reactivation indicates that
antioxidants and anti-inflammation drugs could be promising preventive and therapeutic agents for effectively targeting
KSHV replication and KSHV-related malignancies.
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Introduction
A hallmark of herpesviral infections is the establishment of latency
in the hosts following acute infections [1]. Reactivation of
herpesviruses from latency results in production of infectious virions
and often development of their associated diseases. KSHV is a
gammaherpesvirus associated with KS, a vascular malignancy of
endothelial cells commonly seen in AIDS patients [2]. KSHV is also
linked to other lymphoproliferative diseases including primary
effusion lymphoma (PEL) and multicentric Castleman’s disease
(MCD) [2–4]. Similar to other herpesviruses, KSHV establishes a
lifelongpersistentinfectioninthehost[1].InKStumors,mosttumor
cells are latently infected by KSHV, indicating an essential role of
viral latency in tumor development [5]. However, KSHV lytic
replication also contributes to KS pathogenesis [6]. Both viral lytic
products and de novo infection promote cell proliferation, invasion,
angiogenesis, inflammation and vascular permeability [6]. In fact,
higher KSHV lytic antibody titers and peripheral blood viral loads
are correlated with high incidenceand advanced stage ofKS [7–13],
and KS regressed following anti-herpesviral treatments that inhibit
lytic replication [14,15].
While several cellular pathways such as mitogen-activated protein
kinase (MAPK)pathwaysand proteinkinase Cdelta regulate KSHV
lytic replication [16–20], the common physiological trigger that
reactivates KSHV from latency in patients remains unclear. A
number of factors including proinflammatory and proangiogenic
cytokines [21,22], hypoxia [23], HIV and its product Tat [24–26],
coinfection with human cytomegalovirus and human herpesvirus 6
[27,28], and the activation of toll-like receptors [29] can cause
KSHV reactivation in cultures. However, none of them is likely the
trigger in all the clinical scenarios, which include different forms of
KS, PEL and MCD. The mechanisms by which these factors
reactivate KSHV from latency also remain unclear.
There are four clinical forms of KS. Patients with all forms of
KS are characterized by high levels of inflammation and oxidative
stress [30,31]. Classical KS, mostly seen in elderly men in the
Mediterranean and Eastern European regions, is ubiquitously
associated with high level of inflammation and oxidative stress
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excessive iron exposure due to high content of iron in the local
soils coupled with bare foot walking is a possible cofactor that can
induce inflammation and oxidative stress [33,34]. In transplanta-
tion KS, inflammation and oxidative stress are common because
of immunosuppression and organ rejection [35]. Patients with
AIDS-related KS (AIDS-KS) have high levels of inflammation and
oxidative stress as a result of host responses to HIV infection and
chronic inflammation [36]. In all clinical forms of KS, inflamma-
tion and oxidative stress are also the hallmarks in the tumors [37].
Both PEL and MCD often coexist with KS, and are commonly
seen in HIV-infected patients [6]. PEL is often found in elderly
men, particularly in HIV-negative cases. Thus, similar to KS
patients, these patients often have high levels of inflammation and
oxidative stress. Since inflammation and oxidative stress induce
ROS, and high level of ROS activates the MAPK pathways [38],
we postulated that ROS, as a result of inflammation and oxidative
stress, might mediate KSHV reactivation from latency.
The most common ROS molecule in non-immune cells is
H2O2, which is mainly produced by mitochondria as a byproduct
of oxidative metabolism [38]. Because high level of H2O2 is
cytotoxic, cells express multiple antioxidant enzymes such as
catalase and glutathione peroxidase to remove H2O2 so that it is
below the detrimental threshold in normal condition. During
oxidative stress, cells produce and release a large amount of H2O2
as a consequence of lost balance between its production and its
scavenging [38]. During infections and inflammatory responses,
host phagocytes such as macrophages and neutrophils produce
and release excessive amounts of H2O2 [39–41]. Thus, KS
patients are deemed to have high levels of H2O2. In this study, we
investigated the physiological role of H2O2 on KSHV reactivation.
Results
H2O2 induces KSHV reactivation through both paracrine
and autocrine mechanisms
To examine the relationship of H2O2 with KSHV lytic
replication, we stably expressed an H2O2-specific yellow fluores-
cent protein (cpYFP) sensor from the HyPer-cyto cassette in
KSHV-infected BCBL1 cells [42]. As previously reported [20], the
majority of BCBL1 cells were latently infected by KSHV but a
small percentage of them underwent spontaneous lytic replication,
which was detected by staining for viral late lytic protein ORF65
(Figure 1A). Notably, these ORF65-positive cells were strongly
positive for cpYFP (Figure 1A). In contrast, ORF65-negative cells
were either weakly positive or negative for cpYFP. Treatment with
12-O-tetradecanoylphorbol-13-acetate (TPA), a common chemical
inducer for KSHV lytic replication, increased the number of lytic
cells, all of which also expressed high level of cpYFP while
ORF65-negative cells remained weakly positive for cpYFP
(Figure 1A). Extended exposure of the images or adjustment of
the contrast showed that almost all the TPA-treated cells were
positive for cpYFP albeit with diverse intensities (data not shown).
These diverse levels of H2O2 among the individual cells could be
due to their different sizes of intracellular antioxidant enzyme
pools. Together, these results showed a close correlation between
high level of intracellular H2O2 and KSHV lytic replication.
To investigate the role of H2O2 in KSHV lytic replication, we
examined whether exogenous H2O2, which uses water channels
(aquaporins) to cross the cell membrane [43], is sufficient to induce
KSHV reactivation. We observed a dose-dependent induction, at
both mRNA and protein levels, of KSHV replication and
transcription activator (RTA) encoded by ORF50, a key transacti-
vator of viral lytic replication (Figure 1B–C), by H2O2. Consistent
with these results, H2O2 increased the expression of several other
KSHV lytic transcripts including ORF57, ORF59, kbZIP (ORF-
K8)andORF65 (Figure1D).Theexpression ofKSHV majorlatent
gene LANA (ORF73) was also increased by 2.2-fold while that of
another latent gene vFLIP (ORF71) remained almost unchanged.
Furthermore, H2O2 increased the expression of viral lytic proteins
ORF65 and ORF59, and production of infectious virions in a dose-
dependent manner (Figure 1E–G).
Wefurtherextendedthe observationtoprimaryhumanumbilical
vein endothelial cells (HUVEC) latently infected by KSHV [44].
Similar to BCBL1 cells, H2O2 increased the expression of viral lytic
transcripts including RTA, ORF57 and ORF-K2 but not latent
transcript vCyclin (Figure 1H). H2O2 also increased the expression
of ORF65 protein (Figure 1I–J). These results indicate that H2O2
induction of KSHV reactivation is not cell type specific.
Next, we determined whether an increase in intracellular H2O2
level is sufficient to induce KSHV reactivation. Treatment of
BCBL1 cells with 3-amino-1, 2, 4-triazole (ATZ), an inhibitor of
H2O2 scavenging enzyme catalase, reduced cellular catalase
activity by 57.2% and increased the intracellular H2O2 level by
2.2-fold (Figure 2A–B). ATZ increased the expression of KSHV
lytic transcripts of RTA, ORF57, ORF59, kbZIP and ORF65
genes, the expression of lytic protein ORF65, and production of
infectious virions (Figure 2C–E). Interestingly, we observed an
additive effect when either H2O2 or ATZ was used together with
TPA to induce KSHV lytic replication (Figure 2C–E).
To confirm that the effect of ATZ on KSHV reactivation was
due to an increase in intracellular H2O2 level, we stably expressed
a siRNA specific to catalase in BCBL1 cells harboring a
recombinant KSHV BAC36 [45]. Compared to cells stably
expressing a scrambled siRNA, those expressing the catalase-
specific siRNA had significantly lower expression levels of catalase
transcript and protein (Figure 2F–G). Similar to treatment with
ATZ, knockdown of catalase increased the expression of KSHV
lytic transcripts of RTA, ORF57, ORF59, kbZIP and ORF65,
lytic protein ORF65, and production of infectious virions
(Figure 2F–H).
Taken together, our results so far have shown that an increase in
intracellular or exogenous H2O2 level induces KSHV reactivation,
indicating that H2O2 produced during inflammation and oxidative
Author Summary
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the
etiologic agent of all clinical forms of Kaposi’s sarcoma
(KS) and several other malignancies. The life cycle of KSHV
consists of latent and lytic phases. While establishment of
viral latency is essential for KSHV to evade host immune
surveillances, viral lytic replication promotes KSHV-induced
malignancies. In this study, we show that the reactive
oxygen species (ROS) hydrogen peroxide (H2O2) induces
KSHV reactivation from latency. Furthermore, induction of
KSHV reactivation by oxidative stress, hypoxia, and
proinflammatory and proangiogenic cytokines, which are
physiological hallmarks in all clinical forms of KS patients, is
mediated by H2O2. Significantly, antioxidants inhibit H2O2-
induced KSHV lytic replication in culture and in a mouse
model of KSHV-induced lymphoma. These results show
that ROS is likely an important physiological cue that
triggers KSHV replication. The discovery of this novel
mechanism of KSHV reactivation indicates that antioxi-
dants and anti-inflammation drugs might be promising
preventive and therapeutic agents for effectively targeting
KSHV replication and KSHV-related malignancies.
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reactivates KSHV from latency through both autocrine and
paracrine mechanisms.
H2O2 scavengers inhibit H2O2-induced KSHV lytic
replication
To determine whether H2O2 is required for KSHV lytic
replication, we used H2O2 scavengers to reduce the intracellular
H2O2 level. As shown in Figure 1A, TPA not only induced KSHV
reactivation butalsoincreased the intracellular H2O2 level. At 12 h,
TPA increased the intracellular H2O2 level by 3.9-fold (Figure 3A),
which could be the result of reduced expression of catalase
(Figure 3B). Treatment with H2O2 scavengers including catalase,
reduced glutathione and NAC inhibited TPA induction of
intracellular H2O2 as shown by the reduced median fluorescent
levels in the cpYFP-expressing BCBL1 cells (Figure 3C). None of
these treatments affected the viability and growth rate of the cells
(data not shown). As expected, H2O2 scavengers inhibited TPA
induction of RTA transcript and protein (Figure 3D–E). Consistent
with these results, RTA promoter activities were induced 2.2- and
4.3-fold by H2O2 and TPA, respectively, and these induction effects
were inhibited by NAC (Figure 3F). In contrast, a latent LANA
promoterwasnotinduced byH2O2 and onlymarginallyinduced by
TPA for 1.4-fold (Figure 3G). NAC also abolished TPA induction of
the LANA promoter activity. Furthermore, TPA induction of
ORF65 protein and production of infectious virions were inhibited
by H2O2 scavengers in a dose-dependent fashion (Figure 3H–I). To
examine whether H2O2 scavengers also inhibit KSHV spontaneous
lytic replication, we measured the expression of ORF65 protein in
BCBL1 cells treated with the scavengers. As shown in Figure 3J,
both catalase and NAC inhibited the expression of ORF65 protein
after 6 days but not 1 day of treatment, which is consistent with the
late expression kinetics of this viral capsid protein. These results
indicate that H2O2 is required for KSHV spontaneous lytic
replication and TPA-induced KSHV reactivation, and antioxidants
such as reduced glutathione and NAC can suppress KSHV lytic
replication.
H2O2 scavengers inhibit KSHV lytic replication induced by
hypoxia, and proinflammatory and proangiogenic
cytokines
Because high levels of hypoxia, and proinflammatory and
proangiogenic cytokines are features of KS tumors, and previous
studies have shown that these conditions can induce KSHV
reactivation [21–23], we determined whether KSHV reactivation
induced by these conditions is mediated by H2O2. Short-time
treatment with sodium azide (NaN3), which induces hypoxia [46],
increased intracellular H2O2 level as shown by cpYFP fluorescent
level in BCBL1 cells (Figure 4A–B). As a result, the expression of
RTA transcript was increased 12.2-fold by NaN3, which was
inhibited by both NAC and catalase (Figure 4C). Similarly, the
expression of RTA and ORF65 proteins were induced by NaN3,
which was also inhibited by NAC and catalase (Figure 4D). As
expected, HIF-1a was induced by NaN3, which was also inhibited
by NAC and catalase, suggesting that H2O2 mediates hypoxia
induction of HIF-1a. These results are consistent with previous
observations that H2O2 can directly induce HIF-1a [47].
Next, we determined the role of H2O2 in KSHV reactivation
induced by proinflammatory and proangiogenic cytokines. Treat-
ment of BCBL1cells with vascular endothelial growth factor (VEGF),
fibroblast growth factor-B (bFGF), interleukin-6 (IL-6) or tumor
necrosis factor-alpha (TNF-a) alone minimally induced the expres-
sion of ORF65 protein by 1.5-, 1.2-, 1.4- and 1.2-fold, respectively,
and these induction effects were reversed by NAC and catalase
(Figure4E).Incontrast,insulin-likegrowthfactor-1(IGF-1),epithelial
growth factor (EGF) and interferon gamma(IFN-c)w e r em o r ep o t e n t
inducers, which increased the expression of ORF65 protein by 2.6-,
2.3- and 3.2-fold, respectively. Similarly, NAC and catalase inhibited
theinductionofORF65proteinsbythesecytokines.SinceKStumors
contain abundant infiltration of proinflammatory immune cells such
as monocytes, we further examined the effects of proinflammatory
and proangiogenic cytokines on KSHV reactivation in the presence
of monocytic cells U937 (Figure 4E). Co-culture of BCBL1 cells with
U937 cells alone increased the expression of ORF65 protein by 2.4-
fold. In the presence of U937 cells, weak inducers VEGF, bFGF, IL-6
and TNF-a more effectively increased the expression of ORF65
protein by 3.5-, 2.8-, 4.2- and 7-fold, respectively, suggesting a
synergistic effect of these cytokines with U937 cells. These synergistic
effects were also observed with strong inducers EGF and IFN-c,
which increased the expression of ORF65 protein by 5.2- and 10-fold
in the presence of U937 cells. In contrast, IGF-1 did not further
increase the expression of ORF65 protein in the presence of U937
cells. Both NAC and catalase inhibited the induction of ORF65
protein by proinflammatory and proangiogenic cytokines in the
presence of U937 cells (Figure 4E). Together, these results indicate
that H2O2 mediates KSHV reactivation induced by proinflamma-
tory and proangiogenic cytokines with and without co-culture with
the monocytic cells.
H2O2 scavenger NAC inhibits KSHV lytic replication and
tumor progression in vivo
We next sought to inhibit KSHV lytic replication in vivo with
H2O2 scavengers. To monitor KSHV lytic activity in vivo,w e
generated a recombinant KSHV D65Luc by replacing ORF65
with a firefly luciferase gene (Figure S1A–C). Because ORF65 is a
late viral lytic gene, detection of its expression would imply nearly
complete KSHV lytic replication cycle. We reconstituted D65Luc
Figure 1. Exogenous H2O2 induces KSHV reactivation in PEL and endothelial cells. (A) Cells undergoing lytic replication in both uninduced
BCBL1 cells and BCBL1 cells induced for lytic replication with phorbol ester TPA for 48 h also had high level of intracellular H2O2. Lytic cells were
identified by staining for ORF65 protein (red), a late KSHV lytic protein while intracellular H2O2 level was monitored with a H2O2 sensor protein cpYFP.
DAPI was used to label the nuclei. (B–C) Exogenous H2O2 induced the expression of KSHV RTA transcript and protein in BCBL1 cells in a dose-
dependent manner. Cells were induced for 24 h. RTA transcript was detected by RT-qPCR (B). RTA protein was detected by Western-blotting using
b-tubulin for calibration of sample loading (C). (D) Exogenous H2O2 induced the expression of KSHV lytic transcripts of ORF57, ORF59, kbZIP and
ORF65 in BCBL1 cells detected by RT-qPCR while latent transcripts of LANA and vFLIP had minimal changes. Cells were induced for 24 h. (E–G)
Exogenous H2O2 induced the expression of KSHV lytic proteins ORF65 and ORF59, and production of infectious virions in BCBL1 cells in a dose-
dependent manner. ORF65 was detected by Western-blotting following 96 h of induction using b-tubulin for calibration of sample loading (E). ORF59
protein was detected by immunofluorescence staining following 48 h of induction (F). Relative virus titers were determined by using supernatants
collected at 5 days of treatment to infect endothelial cells and calculating the numbers of GFP-positive cells at 48 hpi (G). (H) Exogenous H2O2
(150 mM) induced the expression of KSHV lytic transcripts of RTA, ORF57, ORF59, and ORF-K2 but not latent vCyclin transcript detected by RT-qPCR in
latent KSHV-infected primary human umbilical vein endothelial cells (HUVEC). Cells were induced for 24 h. (I–J) Exogenous H2O2 (150 mM) induced
the expression of KSHV lytic protein ORF65 in latent KSHV-infected HUVEC. ORF65 was detected by immunofluorescence staining following 96 h of
induction (I). Quantification of ORF65-positive cells (J).
doi:10.1371/journal.ppat.1002054.g001
ROS Induction of KSHV Reactivation
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KSHV and D65Luc. As expected, BAC36-D65Luc cells expressed
low level of ORF65 protein and luciferase, reflecting the
spontaneous viral lytic replication in a small number of cells
(Figure S1D). Treatment with TPA increased the expression of
ORF65 and luciferase proteins. The corresponding luciferase
activity was also increased by 6.2-fold (Figure S1E). These results
indicate that the luciferase activity closely mimicked the expression
of ORF65 protein, and thus can be used to monitor KSHV lytic
activity. As expected, addition of NAC inhibited the luciferase
activity in a dose-dependent manner (Figure 5A).
To examine KSHV lytic replication and determine the
inhibitory effect of antioxidant NAC in vivo, we intraperitoneally
inoculated NOD/SCID mice with BCBL1 cells harboring
D65Luc. The mice were then fed daily with drinking water
containing 5 mM NAC. All mice developed PEL at about five
Figure 2. Intracellular ROS H2O2 induces KSHV reactivation. (A–B) Treatment of BCBL1 cells with catalase inhibitor ATZ reduced catalase
activity (A) and increased intracellular H2O2 level (B). Cells were treated with 1 mM of ATZ for 12 h. (C–E) Induction of KSHV lytic replication in BCBL1
cells by treatment with ATZ, H2O2 and TPA alone or in combination. ATZ was used at 1 mM, H2O2 at 300 mM, and TPA at 20 ng/ml. KSHV RTA, kbZIP,
ORF65 and vFLIP transcripts were detected by RT-qPCR following 24 h of treatment (C). Relative lytic protein ORF65 protein levels shown in numbers
were detected by Western-blotting following 96 h of treatments using b-tubulin for calibration of sample loading (D). Relative virus titers were
measured by using the supernatants to infect endothelial cells and calculating the numbers of GFP-positive cells at 48 hpi (E). (F–H) Silencing of
catalase induced KSHV lytic replication. BCBL1 cells harboring BAC36 were stably transfected with siRNA specific to catalase or scrambled control.
Transcripts of catalase, and KSHV RTA, kbZIP, ORF57, ORF59 and ORF65 were measured by RT-qPCR (F). Catalase, KSHV lytic protein ORF65, and
b-tubulin were detected by Western-blotting (G). Relative virus titers were measured as described in ‘‘E’’ (H).
doi:10.1371/journal.ppat.1002054.g002
ROS Induction of KSHV Reactivation
PLoS Pathogens | www.plospathogens.org 5 May 2011 | Volume 7 | Issue 5 | e1002054Figure 3. TPA-induced KSHV reactivation is mediated by H2O2. (A) Intracellular H2O2 levels in untreated BCBL1 cells and BCBL1 cells treated
with TPA for 6 h. (B) Catalase protein levels in untreated BCBL1 cells and BCBL1 cells treated with TPA for 6 and 12 h. Catalase protein was detected
by Western-blotting and calibrated with b-tubulin for sample loading. (C) H2O2 scavengers reduced TPA-induction of intracellular H2O2 levels
measured by flow cytometry analysis of fluorescence intensity in BCBL1 cells stably expressing a H2O2 sensor protein cpYFP. Cells were treated with
20 ng/ml of TPA without any scavengers, or with scavenger catalase at 400 U/ml, reduced glutathione at 400 mM or NAC at 400 mM for 6 h. (D–E)
H2O2 scavengers reduced TPA-induction of RTA transcript and protein in BCBL1 cells. Treatments of the cells were the same as in (C). RTA transcript
was detected by RT-qPCR (D). RTA protein was detected by Western-blotting and calibrated with b-tubulin for sample loading (E). (F–G) H2O2
mediated the activation of lytic RTA but not latent LANA promoter. RTA promoter was induced by H2O2 and TPA, and this induction effect was
inhibited by NAC (F). Latent LANA promoter was marginally activated by TPA but not by H2O2 (G). Luciferase activities were measured for 293 cells
ROS Induction of KSHV Reactivation
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fed with NAC had an average 15.6-fold lower luciferase activities
than those fed with drinking water alone (Figure 5B–C). We also
detected lower expression levels of ORF65 protein in lymphoma
cells isolated from the NAC-treated mice than those from the
control mice by Western-blotting (Figure 5D). Immunohistochem-
ical staining showed that the majority of the lymphoma cells from
both groups were positive for LANA; however, cells from NAC-
treated mice had significantly lower number of ORF65-positive
cells than those from the control group (Figure S2A–B). To
determine the production of infectious virions by the lymphoma
cells, we used cell-free supernatants from the pleural fluids of the
mice to infect HUVEC and examined the presence of infectious
virions by staining for ORF65 protein [49]. We observed
abundant virus particles in many of the cells infected with
supernatants from the control mice while those infected with
supernatants from NAC-treated mice had almost no detectable
virus particles (Figure S2C). Consistent with these results, mice fed
with NAC had an average 2.7-fold lower virus loads in the blood
than the control group (Figure 5E). As many as 50% of the mice
from both groups also developed solid tumors. ORF65 protein was
detected in over 10% of the tumor cells from the control solid
tumors but was almost not detectable in the solid tumors from the
NAC-treated mice (Figure S2D). By examining the survival curves,
we found that NAC-treated mice had an extended lifespan
compared to the control group (Figure 5F). At 12-week post-
inoculation, 72.2% of the NAC-treated mice survived compared to
only 45.4% in the untreated group (P=0.016). Collectively, results
from these in vivo experiments indicated that PEL induced in mice
had active KSHV lytic replication, and antioxidant NAC
effectively inhibited KSHV lytic replication, and extended the
lifespan of the mice.
H2O2 induces KSHV reactivation by activating the ERK1/2,
JNK and p38 MAPK pathways
H2O2 is known to activate multiple MAPK pathways [50],
which are required for KSHV lytic replication [17,20]. Similar to
TPA, both exogenous and ATZ-induced endogenous H2O2
activated ERK1/2, JNK, and p38 MAPK pathways, and
increased the total and phosphorylated forms of their downstream
target c-Jun in a dose-dependent manner in BCBL1 cells in
addition to induction of RTA protein expression (Figure 6A).
Treatment with specific inhibitors of all three MAPK pathways
effectively inhibited TPA activation of their respective MAPKs
and c-Jun, as well as the induction of RTA protein (Figure 6A).
Importantly, these inhibitors also strongly inhibited H2O2 and
ATZ induction of RTA expression and production of infectious
virions (Figure 6B–C).
To further confirm the essential roles of MAPK pathways in
H2O2-induced KSHV reactivation, we used dominant negative
(DN) constructs to block these pathways. In 293T cells harboring
BAC36, treatment with TPA induced KSHV reactivation [51].
Treatment with H2O2 and ATZ induced the expression of RTA
transcript (Figure 6D). As expected, DN constructs of all three
MAPK pathways and c-Jun effectively inhibited the induction of
RTA by TPA and H2O2 (Figure 6E). Together, these results
indicate that H2O2 induction of KSHV reactivation is mediated
by all three MAPK pathways.
Discussion
We have shown that ROS H2O2 induces KSHV lytic
replication through both paracrine and autocrine mechanisms,
and in both PEL and endothelial cells. Because oxidative stress
and chronic inflammation are characteristic features in patients of
all clinical forms of KS, as well as PEL and MCD [6,30,31], H2O2
could be an important physiological factor that triggers KSHV
reactivation in these patients. Several other factors that induce
KSHV lytic replication [21–29] also induce oxidative stress and
inflammation [36,52–56]. Thus, it is likely that H2O2 mediates
KSHV lytic replication induced by these factors. Indeed, our data
show that KSHV reactivation induced by oxidative stress,
hypoxia, and proinflammatory and proangiogenic cytokines
depends on the induction of H2O2. Importantly, co-culture of
BCBL1 cells with monocytic U973 cells enhances KSHV
reactivation induced by proinflammatory and proangiogenic
cytokines, particularly IL-6, TNF-a and IFN-c, which are highly
expressed in KS tumors [6]. Because of the abundance of
proinflammatory cells, and proinflammatory and proangiogenic
cytokines in KS tumors, these synergistic effects could further
boost KSHV lytic replication. Thus, tumor microenvironments
consisting of proinflammatory cells, proinflammatory and proan-
giogenic cytokines, and possibly extracellular matrix and other
stromal cells are likely to have essential roles in inducing and
mediating KSHV lytic replication in KS tumors, which should be
further examined in more details.
Mechanistically, we have shown that H2O2 induction of
KSHV reactivation is mediated by ERK, JNK, and p38 MAPK
pathways. Previous studies have shown that these pathways are
required for KSHV infection and lytic replication [17–20].
Consistent with these observations, oxidative stress, hypoxia, and
a number of proinflammatory and proangiogenic cytokines are
known to induce MAPK pathways [57–65].
Based on our results, we propose a model in which KS tumors
are initiated by either the homing of KSHV-infected cells, most
likely progenitor endothelial cells or B-cells, from virus reservoirs
to the affected sites or de novo infection by the newly produced
virions, both of which are promoted by inflammation and
oxidative stress [6]. Since KSHV de novo infection and lytic
replication further promote inflammation and oxidative stress
[6], one can expect the establishment of a positive feedback loop
once the cycle is initiated. If these inflammatory conditions are
not appropriately contained, they can lead to the rapid
progression of KS as in the case of untreated AIDS-KS.
Therefore, both active inflammation and host control of viral
replication are likely to determine the course of KS.
It is interesting that only a subset of KSHV-infected cells
undergo lytic replication in KS tumors or in cell culture induced
for KSHV lytic replication (Figure 1A and F). KSHV has
evolved a complex mechanism consisting of multiple blocks to
regulate its replication [66]. Whether a cell undergoes lytic
replication is likely to depend on the extent of release of these
blocks. While KSHV lytic replication induces inflammation and
transfected with promoter reporter plasmids for 24 h, and treated with H2O2 (150 mM) or TPA (20 ng/ml) with or without NAC (400 mM) for 12 h.
(I–H) H2O2 scavengers reduced TPA-induction of ORF65 protein and production of infectious virions in BCBL1 cells in a dose-dependent manner. TPA
was used at 20 ng/ml. Relative ORF65 protein levels shown in numbers were detected following 72 h of treatment by Western-blotting and
calibrated with b-tubulin for sample loading (H). Relative virus titers were determined by using supernatants collected at 5 days of treatment to infect
endothelial cells and calculating the numbers of GFP-positive cells at 48 hpi (I). (J) H2O2 scavengers inhibited KSHV spontaneous lytic replication.
ORF65 protein in BCBL1 cells treated with catalase (400 U/ml) and NAC (400 mM) for 1 and 6 day was determined by Western-blotting.
doi:10.1371/journal.ppat.1002054.g003
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PLoS Pathogens | www.plospathogens.org 7 May 2011 | Volume 7 | Issue 5 | e1002054Figure 4. H2O2 mediates KSHV reactivation induced by hypoxia, and proinflammatory and proangiogenic cytokines. (A–B) Sodium
azide (NaN3) and TPA increased intracellular H2O2 levels measured by flow cytometry analysis of fluorescence intensity in BCBL1 cells stably
expressing a H2O2 sensor protein cpYFP. Cells were treated with NaN3 (10 mM) for 90 min or 20 ng/ml of TPA for 12 h, and their fluorescence levels
measured by flowcytometry shown in histogram (A) and median fluorescence intensity (B). (C) H2O2 scavengers inhibited NaN3 induction of RTA
transcript. BCBL1 cells were treated with NaN3 (10 mM) for 90 min with and without NAC (400 mM) or catalase (400 U/ml). RTA transcript was
detected by RT-qPCR following elimination of NaN3, and continuous culture with NAC or catalase for another 24 h. (D) H2O2 scavengers inhibited
NaN3 induction of HIF-1a, RTA and ORF65 proteins. BCBL1 cells were treated with NaN3 (10 mM) for 90 min with and without NAC (400 mM) or
catalase (400 U/ml). Following elimination of NaN3, cells were cultured with NAC or catalase, and Western-blotting was performed to measure the
expression of HIF-1a protein at 6 h, RTA protein at 24 h, and ORF65 protein at 72 h. (E) H2O2 scavengers inhibited the expression of ORF65 protein in
BCBL1 cells induced by proinflammatory and angiogenic cytokines. ORF65 protein was determined by Western-blotting in BCBL1 cells with or
without co-culture with U973 cells treated with cytokines with or without NAC (400 mM) or catalase (400 U/ml) for 72 h. The concentrations of the
cytokines were stated in the Materials and Methods. Relative ORF65 protein level was calculated using untreated BCBL1 cells as a reference (1-fold)
and after calibration for protein loading with b-tubulin.
doi:10.1371/journal.ppat.1002054.g004
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mechanism, it is also detrimental to the lytic cells [6]. Thus, a
fine balance of latent and lytic programs in KS tumors combined
with active inflammation and oxidative stress in the tumor
microenvironment is likely required for the development of
advanced stage of KS.
We have shown that H2O2 scavengers such as NAC can inhibit
KSHV lytic replication in vitro and in a KSHV lymphoma animal
Figure 5. Antioxidant NAC inhibits spontaneous KSHV lytic replication in vitro and in vivo. (A) NAC inhibited the luciferase activities of
BCBL1 cells harboring D65Luc in a dose-dependent fashion. The luciferase activities were measured following 72 h of treatment. (B-E) NAC inhibited
KSHV lytic replication in a mouse PEL model. NOD/SCID mice intraperitoneally inoculated with BCBL1 cells harboring D65Luc at 5610
6 cells per
mouse were examined for evidence of KSHV lytic replication. Representative images of the untreated control and NAC-treated groups of mice
examined for luciferase activities five weeks after inoculation using a Xenogen IVIS 200 small animal imaging system (B). Luciferase activities of the
untreated control (N=44) and NAC-treated mice (N=36) (C). Detection of KSHV ORF65 protein by Western-blotting in lymphoma cells from
representative mice (D). Cells from 100 ml ascitic fluid from each mouse were examined. b-tubulin was used to calibrate the number of total cells.
Relative viral loads in blood samples of control and NAC-treated mice (E). Kaplan-Meier analysis of the survival of the two groups of mice showing
that NAC treatment significantly extended the lifespan of the mice compared to untreated mice (F).
doi:10.1371/journal.ppat.1002054.g005
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PLoS Pathogens | www.plospathogens.org 9 May 2011 | Volume 7 | Issue 5 | e1002054Figure 6. H2O2 induction of KSHV reactivation is mediated by ERK1/2, JNK, and p38 MAPK pathways. (A) Treatment with H2O2, ATZ or
TPA activated ERK1/2, JNK and p38 pathways and their downstream transcriptional factor c-Jun, and induced the expression of RTA protein in BCBL1
cells harboring BAC36. Cells were treated with different concentrations of H2O2 and ATZ, or TPA at 20 ng/ml with DMSO control or inhibitors of MAPK
pathways including 10 mM U0126 (ERK inhibitor), 50 mM JNK inhibitor II, and 50 mM SB203580 (p38 inhibitor) for 12 h. Total ERK1/2, JNK, p38 and
c-Jun, and their phosphorylated forms, RTA protein, and b-tubulin were detected by Western-blotting. (B–C) Inhibitors of MAPK pathways inhibited
the induction of RTA and production of infectious virions by H2O2, ATZ and TPA in BCBL1 cells harboring BAC36. H2O2, ATZ and TPA were used at
concentrations of 300 mM, 5 mM and 20 ng/ml, respectively. Inhibitors of MAPK pathways were used at concentrations described in (A). Relative RTA
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bearing mice. These results indicate that antioxidants and anti-
inflammation drugs might be effective for inhibiting KSHV lytic
replication, and thus could be promising preventive and
therapeutic agents for KSHV-induced malignancies. Because
many of these agents are affordable, their use is attractive,
particularly in the African settings.
Materials and Methods
Cell culture and chemical reagents
BCBL1 cells and BCBL1 cells carrying pHyer-cyto or BAC36, a
recombinant KSHV [45], were cultured in RPMI 1640
supplemented with 10% fetal bovine serum (FBS). Human
embryonic kidney 293T cells, 293 cells and 293T cells carrying
BAC36 were cultured in DMEM plus 10% FBS.
H2O2, ATZ, NaN3, and antioxidants NAC, reduced L-
glutathione, and bovine liver catalase were purchased from Sigma
Life Science (St. Louis, MO). The ERK inhibitor U0126, p38
inhibitor SB203580, and JNK inhibitor JNK inhibitor II were all
purchased from Calbiochem (Gibbstown, NJ). TPA was from
Sigma.
Plasmids and lentiviruses
The p38 DN plasmid pcDNA3-p38/AF was provided by Jiahua
Han at The Scripps Institute [67]. The JNK DN (HA-JNK1
[APF]) plasmid was from Lin Mantell at New York University
School of Medicine [68]. The ERK DN (pCEP4L-HA-
ERK1K71R) plasmid was from Melanie Cobb at the University
of Texas Southwestern Medical Center [69]. The c-Jun DN
plasmid pCMV-TAM67 was from Bradford W. Ozanne at
Beatson Institute [70]. The pHyPer-cyto plasmid was purchased
from Biocompare (South San Francisco, CA). Transfection of
293T and BCBL1 cells was carried out using the Lipofectamine
LTX Reagent from Invitrogen (Carlsbad, CA). The lentiviruses
expressing specific siRNA to human catalase and scrambled
control were purchased from Santa Cruz (Santa Cruz, CA).
BCBL1-BAC36 cells stably expressing catalase-specific or scram-
bled siRNAs were obtained following lentiviral infection and
puromycin selection according to the instructions of the manu-
facturer.
Measurement of cellular catalase activity and intracellular
level of H2O2
A total of 5610
6 BCBL1 cells cultured with or without ATZ
or TPA for 12 h were harvested by brief centrifugation. The cell
pellets were homogenized in 0.5 ml ice cold phosphate saline
buffer at pH 7.4 containing 1 mM EDTA. After centrifugation
at 10,000 g for 15 min at 4uC, the supernatants were collected
and used for measuring catalase activity or intracellular H2O2.
Cellular catalase activity was determined with the OxiSelect
Catalase Activity Assay Kit (Cell Biolabs, San Diego, CA), and
intracellular H2O2 determined with the Fluorescent Hydrogen
Peroxide/Peroxidase Detection Kit from Cell Technology
(Columbia, MD). Alternatively, we tracked the intracellular
H2O2 level with a H2O2 sensor by stable transfection of BCBL1
cells with a HyPer-cyto cassette consisting of a circularly
permuted yellow fluorescent protein (cpYFP) under the control
of the regulatory domain of the prokaryotic H2O2-sensing
protein, OxyR [42].
Induction of viral lytic replication and titration of
infectious virions
To induce viral lytic replication, 2610
6 BCBL1 cells were
treated with H2O2, ATZ or TPA alone, or in combination, in
10 ml RPMI 1640 medium containing 10% FBS for 48 h. The
cells were then harvested, washed 1 time by centrifugation to
eliminate the chemicals, and cultured in 5 ml fresh RPMI 1640
media with 10% FBS for three additional days. The supernatants
were collected following centrifugation to eliminate cells and cell
debris at 5,000 g for 15 min, and used for titration as previously
described [44]. Relative virus titers were calculated based on the
numbers of GFP-positive cells. Detection of virus particles in
lymphoma supernatants from mice was carried out by staining for
ORF65 with a monoclonal antibody following infection of
HUVEC for 4 h as previously described [49].
To examine the effects of antioxidants on KSHV spontaneous
lytic replication, BCBL1 cells were cultured in the presence NAC
(400 mM) or catalase (400 U/ml) for 1 or 6 day, and cells were
collected for Western-blotting analysis of ORF65 protein.
For induction of lytic replication by hypoxia, BCBL1 cells at
1.5610
7 cells/ml were treated with 10 mM NaN3 with or without
antioxidants NAC (400 mM) and catalase (400 U/ml) for 90 min.
Following washing by centrifugation, the cells were cultured for
the specified lengths of time with or without NAC and catalase.
For induction of lytic replication by cytokines, BCBL1 cells at
1.5610
7 cells/ml were cultured in fresh medium with cytokines with
or without antioxidants NAC (400 mM) and catalase (400 U/ml) for
72 h, and collected for Western-blotting. In parallel induction
experiments, BCBL1 cells at 1.5610
7 cells/ml in fresh medium were
induced with cytokines with or without antioxidants by co-culture
with U937 cells at 5610
4 cells/ml pretreated with cytokines with or
without antioxidants for 4 h. The following cytokines and concen-
trations were used: recombinant human VEGF at 200 ng/ml(Lonza,
Walkersville, MD), recombinant human long R IGF-1 at 200 ng/ml
(Lonza), recombinant human bFGF at 200 ng/ml (Lonza), recom-
binant human EGF at 200 ng/ml (Lonza), human IL-6 at 1 mg/ml
(R&D Systems, Minneapolis, MN), human TNF-a at 1 mg/ml(R&D
Systems) and human IFN-c at 4000 U/ml (Sigma).
To induce KSHV lytic replication in endothelial cells, latent
KSHV-infected HUVEC obtained as previously described [44]
were treated with H2O2 (150 mM) for 24 h or 72 h, and cells were
collected for RNA analysis or immunostaining for ORF65 protein,
respectively.
RNA extraction and quantitative reverse transcription
real-time PCR (RT-qPCR)
RNA was purified using a Total RNA Purification Kit
(Promega, Madison, WI). Total RNA (10 mg) was reversely
transcribed into first-strand cDNAs by using a Superscript III
transcript level at 24 h of treatment was detected by RT-qPCR with untreated cells set as ‘‘1’’ (B). Relative virus titers were determined by using
supernatants collected at 5 days of treatment to infect endothelial cells and calculating the numbers of GFP-positive cells at 48 hpi (C). Virus titers
from untreated cells were set as ‘‘1’’. (D) H2O2 and ATZ, and TPA at concentrations of 300 mM, 5 mM and 20 ng/ml, respectively, induced the
expression of RTA transcript in 293T cells harboring BAC36. RTA transcript was detected by RT-qPCR following 24 h of treatment. (E) Dominant
negative (DN) constructs of MAPK pathways inhibited the induction of RTA transcript by H2O2 and TPA in 293T cells. 293T cells harboring BAC36 were
transiently transfected with the control plasmid and DN constructs of ERK, JNK, p38, and c-Jun for 24 h, and treated with H2O2 at 300 mM and TPA at
20 ng/ml for an additional 12 h.
doi:10.1371/journal.ppat.1002054.g006
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carried out in a DNA Engine Opticon 2 Continuous Fluores-
cence Detector (Bio-Rad, Hercules, CA). Each sample was
measured in triplicate. The expression level of each transcript
(mRNA) was first normalized to b-actin mRNA as previously
described [71]. The relative expression level of a transcript in the
treated cells was compared to the untreated cells, and calculated
as fold changes. Specific primers for all KSHV genes were
previously described [71]. Primers for human catalase were:
59aggactaccctctcatcccagttg39 (forward) and 59gggtcccaggc-
gatggcggtgag39 (reverse).
Immunofluorescence antibody assay (IFA),
immunohistochemistry and Western-blotting
KSHV lytic proteins ORF59 or ORF65 in BCBL1 cells were
detected by IFA as previously described [51]. Expression of KSHV
lytic proteins in lymphomas and solid tumors in mice were
detected by immunohistochemistry. Briefly, cells from PEL
induced in NOD/SCID mice were collected by centrifugation at
1,000 g for 5 min, fixed with formalin, and embedded in paraffin.
Sections at 5 nm cut from the paraffin blocks were deparaffinized
at 60uC, cleared, and rehydrated in xylene and graded alcohols.
Antigen retrieval was done with citrate buffer at pH 6 for 20 min
at 121uC in a pressure chamber. Sections were blocked
successively with 3% H2O2 and bovine serum albumin buffer.
Sections were then incubated with a monoclonal antibody to
ORF65 or a mouse immunoglobulin fraction (DAKO, Carpin-
teria, CA) as a negative control for 1 h at 25uC. After three washes
with PBS, the slides were further incubated with a secondary
antibody conjugated to horseradish peroxidase (DAKO) for
15 min. The slides were then incubated with the diaminobenzi-
dine substrate (DAKO), counterstained with hematoxylin, and
mounted for observation.
Western-blotting was carried out as previously described [51].
The rabbit polyclonal antibodies to ERK1, p-ERK (Tyr 204),
JNK1, p-JNK (Thr 183/Tyr 185), p38, p-p38 (Tyr 182), c-Jun,
and catalase were from Santa Cruz; a polyclonal antibody to p-c-
Jun (Ser73) was from Calbiochem; and a monoclonal antibody to
b-tubulin was from Sigma. A rabbit polyclonal antibody to KSHV
lytic protein RTA was a generous gift from Dr. Charles Wood at
the University of Nebraska, Lincoln.
Reporter assay
293 cells transfected with either the RTA promoter luciferase
reporter plasmid or the latent LANA promoter (LTd) luciferase
reporter plasmid using Lipofectamine-2000 Transfection Reagent
(Invitrogen) for 24 h were treated with H2O2 (300 mM) or TPA
(20 ng/ml) with or without antioxidants NAC (400 mM) or
catalase (400 U/ml) for 12 h. Cells were collected and their
luciferase activities determined as previously described [51].
Transfection efficiency was calibrated by co-transfection with the
pSV-b-galactosidase construct (Promega).
Detection of blood viral loads in mice
Cell-free DNA was isolated from two drops of blood from each
mouse collected by tail bleeding using the QiAamp DNA Blood
Mini Kit (Qiagen). KSHV DNA was detected by real-time PCR
using vCyclin (ORF72) primers and purified BAC36 as copy
number control as previously described [71]. KSHV viral loads
expressed as genome copies per ml of blood were calculated. PCR
assay for human b-actin gene was also carried out for these DNA
samples to monitor the absence of any contamination of human
cells [71]. None of the samples had any detectable signal for
human b-actin gene.
Generation of a recombinant KSHV expressing firefly
luciferase under the control of the late lytic ORF65
promoter
A recombinant KSHV genome with the entire ORF65-coding
frame deleted and replaced with the firefly luciferase gene was
constructed using a ‘‘two-step’’ homologous recombination stra-
tegy as previously described (Figure S1A) [51]. Firstly, the firefly
luciferase gene was amplified from the luciferase reporter plasmid
pGL3-Basic Luciferase Reporter Vector (Promega) using primers
59ttctcgagatggaagacgccaaaaacataaagaaaggcccg39 (luciferase forward)
and 59ctcgagttaattaattacacggcgatctttccgcccttc39 (luciferase reverse).
The Kanamycin resistance cassette (Kan
R)f l a n k e db yt w oL o x Ps i t e s
wasamplified fromthe transposon EZ-Tn5
TM ,Kan-2. (Epicenter,
Madison, WI) using primers 59tttttaattaagtgtaggctggagctgcttc39
(Kan
R forward) and 59ttttttaattaacatatgaatatcctccttag39 (Kan
R re-
verse). The two PCR products were ligated using a T4 DNA ligase
(New England Biolabs, Ipswich, MA). The resulting fragment was
then used as a template to generate the Kan
R-Luc cassette by PCR
amplification using primers 59cttgtgactccacggttgtccaatcgttgcctatttcttt-
ttgccagagg tttttaattaagtgtaggctggagctgcttc39 (forward) and 59aggtga-
gagaccccgtgatccaggagcgactggatcatgactacgctcac ttctcgagatggaagacgc-
caaaaacataaagaaaggcccg39 (reverse). This PCR product, flanked by a
50 bp sequencefrom the immediate downstream region of ORF65 at
its 59end and a 50 bp sequence from the start codon (ATG) region of
ORF65 at its 39end, was electroporated into Escherichia coli strain
DH10B containing recombinant KSHV BAC36 [45]. Upon
homologous recombination, the Kan
R-Luc cassette was integrated
into KSHV genome. The Kanamycin-resistant colonies, containing
the mutant KSHV genome, named D65Kan-Luc, with ORF65
replaced with Kan
R-Luc cassette, were selected. To eliminate the
Kan
R cassette, a Cre-expression plasmid pCre carrying a tetracycline
resistant marker and a temperature (37uC)-sensitive replication origin
was electroporated into the selected bacteria. The expression of Cre
protein led to the removal of Kan
R cassette by LoxP-mediated
recombination. The resulting colonies containing the mutant KSHV
genome, named D65Luc, with ORF65 replaced with firefly luciferase
gene,whichwasTetracyclineresistantbutKanamycinsensitive,were
selected. The pCre plasmid was removed by culturing the bacteria at
37uC.
The mutant KSHV genomes were purified using the Large
Construct DNA Purification Kit (Qiagen, Valencia, CA), verified
for integrity by restriction digestion and PCR amplification of
specific genes (Figure S1B–C), and electroporated into BCBL1
cells as previously described [45]. Following Hygromycin selection,
a cell line harboring both the wild type KSHV genome and
D65Luc was established. Expression of luciferase by this cell line
was confirmed by Western-blotting using a luciferase-specific
antibody (Figure S1D), and by measuring luciferase activity
using the firefly luciferase substrate (Promega) and a Veritas
Microplate Luminometer (Turner BioSystems, Sunnyvale, CA)
(Figure S1E).
Examination of the effect of antioxidant NAC on KSHV
lytic replication in a mouse lymphoma model
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Texas Health Science
Center at San Antonio (Animal Welfare Assurance Number:
ROS Induction of KSHV Reactivation
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anesthesia, and all efforts were made to minimize suffering.
Male NOD/SCID mice at 6 weeks from Jackson Laboratories
(Bar Harbor, ME) were intraperitoneally inoculated with BCBL1
cells carrying D65Luc at 5610
6 per mouse. One week after
inoculation, mice (n=36) were given drinking water supplemented
with 5 mM of NAC while the control mice (n=44) were given
drinking water without the antioxidant. Mice were monitored
daily for ‘‘PEL-like’’ symptoms. Luciferase activity and GFP
intensity were measured five weeks after injection using a Xenogen
IVIS 200 Imaging System (Xenogen, Alameda, CA). Mice were
monitored daily, and terminated when they became immobile.
Lymphoma cells, supernatants and solid tumors were collected
and analyzed as indicated.
Supporting Information
Figure S1 Construction of a recombinant KSHV with ORF65
replaced with firefly luciferase gene. (A) Schematic illustration of
the ‘‘two-steps’’ recombination strategy for generating the mutant
KSHV genome. (B) Genetic analysis of wild type BAC36,
intermediate mutant D65Kan-Luc and recombinant virus
D65Luc genomes by restriction digestion with Hind III. (C)
Confirmation of the replacement of ORF65 by luciferase gene in
intermediate mutant D65Kan-Luc and recombinant virus D65Luc
genomes by PCR amplification. (D) Detection of luciferase and
ORF65 proteins in uninduced and TPA-induced BCBL1 cells
harboring D65Luc by Western-blotting. b-tubulin was used for the
calibration of sample loading. TPA treatment was carried out for
72 h. (E) Detection of luciferase activities in uninduced and TPA-
induced BCBL1 cells harboring D65Luc. TPA treatment was
carried out for 72 h.
(TIF)
Figure S2 NAC treatment inhibits KSHV lytic replication in a
mouse PEL model. (A) Representative immunohistochemistry
images of ORF65 and LANA staining in lymphoma cells from
untreated control and NAC-treated mice. (B) Percentages of
ORF65-positive cells in lymphomas from untreated control and
NAC-treated mice. (C) Detection of KSHV particles by ORF65
staining in endothelial cells infected with supernatants of
lymphomas from untreated control and NAC-treated
mice. Immunofluorescence staining was performed at 4 hpi.
(D) Representative immunohistochemistry images of ORF65
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